2.330USD+3.10%Mkt Cap: 19.21M USDP/E: —Last update: 2026-06-01
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone repl…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap19.21M USD
Enterprise Value-6.18M USD
Revenue (TTM)2.00M USD
Gross Profit-6.61M USD
Net Income (TTM)-9.63M USD
Revenue/Share0.3450 USD
Last Price2.330 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.81
PEG—
EV/EBITDA0.51
EV/Revenue-3.09
P/S9.26
P/B0.74
EPS (TTM)-1.96
EPS (Forward)-1.24
52W Range
1.8105% of range12.37
52W High12.37 USD
52W Low1.810 USD
Profitability
Gross Margin-334.26%
Oper. Margin-3224.09%
EBITDA Margin0.00%
Profit Margin-487.06%
ROE-66.50%
ROA-56.61%
Growth
Revenue Growth27.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.76M USD
CapEx (TTM)—
FCF Margin-297.90%
FCF Yield-31.05%
Net Debt-24.73M USD
Net Debt/EBITDA2.05
Balance Sheet
Debt/Equity—
Current Ratio9.99
Quick Ratio9.87
Book Value/Sh3.054 USD
Cash/Share3.000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:17
Split DateMay 12, 2023
Analyst Consensus
Rating—
Target (Mean)6.000 USD
Target Range6.000 USD – 6.000 USD
# Analysts1
Ownership
Shares Out.8.24M
Float6.88M
Insiders4.51%
Institutions44.29%
Short Interest
Short Ratio0.5d
Short % Float1.26%
Short % Out.1.24%
Shares Short102.13K
Short (prev mo.)154.12K
Technical
SMA 503.457 (-32.6%)
SMA 2004.740 (-50.8%)
Beta0.50
S&P 52W Chg27.94%
Avg Vol (30d)129.26K
Avg Vol (10d)85.84K
Technical Indicators
RSI (14)34.8
MACD-0.2750
MACD Signal-0.3786
MACD Hist.+0.1035
BB Upper2.416 USD
BB Middle2.295 USD
BB Lower2.173 USD
BB Width10.61%
ATR (14)0.1732 USD
Vol Ratio (20d)0.73x